Literature DB >> 11991344

Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.

U Patel1, M Agrawal, P Krishnan, S Niranjan.   

Abstract

Neuroleptic malignant syndrome is a rare (incidence, 0.02%-3.2%) but dangerous complication following the use of neuroleptic drugs. When not promptly recognized, this disease carries a high mortality (10%-20%) and morbidity rate. We report an unusual case of neuroleptic malignant syndrome that presented predominantly with autonomic instability in the form of recurrent episodes of respiratory distress. The respiratory distress was initially caused by pulmonary edema and later was caused by severe bronchorrhea. We propose that aspiration pneumonia resulting in respiratory failure, the leading cause of death in neuroleptic malignant syndrome, may be a result of a combination of altered mental status and bronchorrhea. This has therapeutic implications because early institution of bromocriptine/dantrolene can prevent aspiration pneumonia and, hence, mortality from respiratory failure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991344      PMCID: PMC2594215     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  10 in total

Review 1.  [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].

Authors:  M D Andreassen; S Pedersen
Journal:  Ugeskr Laeger       Date:  2000-03-06

Review 2.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

3.  Drug treatment of the neuroleptic malignant syndrome.

Authors:  P Sakkas; J M Davis; P G Janicak; Z Y Wang
Journal:  Psychopharmacol Bull       Date:  1991

4.  An atypical course of neuroleptic malignant syndrome.

Authors:  M E Schneiderhan; P A Marken
Journal:  J Clin Pharmacol       Date:  1994-04       Impact factor: 3.126

5.  Case study: neuroleptic malignant syndrome without pyrexia.

Authors:  A F Hynes; E L Vickar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-07       Impact factor: 8.829

Review 6.  Neuroleptic malignant syndrome presenting without initial fever: a case report.

Authors:  V Y Totten; E Hirschenstein; P Hew
Journal:  J Emerg Med       Date:  1994 Jan-Feb       Impact factor: 1.484

Review 7.  Neuroleptic malignant syndrome presenting without fever: case report and review of the literature.

Authors:  R Lev; R F Clark
Journal:  J Emerg Med       Date:  1994 Jan-Feb       Impact factor: 1.484

Review 8.  Neuroleptic malignant syndrome.

Authors:  S N Caroff; S C Mann
Journal:  Med Clin North Am       Date:  1993-01       Impact factor: 5.456

9.  Neuroleptic malignant syndrome: two cases without muscle rigidity.

Authors:  M M Wong
Journal:  Aust N Z J Psychiatry       Date:  1996-06       Impact factor: 5.744

10.  [Neuroleptic malignant syndrome associated with the syndrome of inappropriate secretion of antidiuretic hormone].

Authors:  K Yamaguchi; K Takamoto; K Yagi; H Tanabe
Journal:  Rinsho Shinkeigaku       Date:  1995-02
  10 in total
  3 in total

Review 1.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

2.  Acute Abdomen with Ileus: A Heralding Presentation of Neuroleptic Malignant Syndrome.

Authors:  Chukwunonso Chime; Ahmed Alemam; Kishore Kumar; Manjeet Dhallu
Journal:  Case Rep Gastroenterol       Date:  2018-09-18

Review 3.  Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.

Authors:  Janet Sultana; Marco Calabró; Ricard Garcia-Serna; Carmen Ferrajolo; Concetta Crisafulli; Jordi Mestres; Gianluca Trifirò'
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.